Benefits and Problems of Transarterial Therapy in Patients with Hepatocellular Carcinoma and Chronic Kidney Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Benefits and Problems of Transarterial Therapy in Patients with Hepatocellular Carcinoma and Chronic Kidney Disease

Published:2014-12 Issue:12 Volume:25 Page:1947-1955
ISSN:1051-0443
Container-title:Journal of Vascular and Interventional Radiology
language:en
Short-container-title:Journal of Vascular and Interventional Radiology

Author:

Watanabe Masaaki,Shibuya Akitaka,Minamino Tsutomu,Murano Junya,Matsunaga Keiji,Fujii Kaoru,Ogasawara Gou,Irie Tsugumi,Woodhams Reiko,Koizumi Wasaburo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Reference20 articles.

1. Impact of renal insufficiency on patients with hepatocellular carcinoma undergoing radiofrequency ablation;Chen;J Gastroenterol Hepatol In press available online,2014

2. Hepatocellular carcinoma in uremic patients: is there evidence for an increased risk of mortality?;Lee;J Gastroenterol Hepatol,2013

3. Hepatocellular carcinoma in patients with chronic kidney disease;Lee;World J Gastroenterol,2013

4. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study;Davila;Gut,2005

5. Chapter 5: Transcatheter arterial chemoembolization;Hepatol Res,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence And Risk Factors Of Contrast Nephropathy After Tace In Patients With Liver Cancer And Chronic Kidney Disease;Clinical and Investigative Medicine;2021-10-03

2. Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges;World Journal of Gastroenterology;2021-07-14

3. Hepatocellular carcinoma in patients with chronic renal disease: Challenges of interventional treatment;Surgical Oncology;2021-03

4. Challenges of transarterial therapy for hepatocellular carcinoma in patients with chronic kidney disease;Medicine;2019-08

5. Time for paradigm change in management of hepatocellular carcinoma: is a personalized approach on the horizon?;Personalized Medicine;2016-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3